Advertisement

Search Results for "Gsk598809"

03:42 EDT 21st May 2013 | BioPortfolio

Original Source: Effects of the D3 Antagonist GSK598809 on Food Reward and Reinforcement

This novel compound is a new experimental treatment that may help people to stop compulsive overeating. Compulsive overeating or binge eating is one of the main reasons why people are overweight or obese. Recent research has shown that some kinds of overeating may be linked to a brain chemical called dopamine. There is some evidence that blocking the action of this chemical in animals can reduce food intake, particularly of foods that are high in fat and sugar. The purpose o...

Matching Channels

None

Matching News

Experimental drug found to reduce nicotine craving

(Medical Xpress)—Researchers at the Aptuit Centre for Drug Discovery and Development in Italy, have found that a drug called GSK598809 is able to block a type of dopamine receptor in the brain that...

Matching PubMed Articles

The effects of the dopamine D3 receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects.

The mesolimbic dopamine system plays a critical role in the reinforcing effects of rewards. Evidence from pre-clinical studies suggests that D3 receptor antagonists may attenuate the motivational impa...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement